Ionis Pharmaceuticals, Inc.’s Post

🗞️ Top Stories of 2023 from the CU School of Medicine 🗞️ Story #1: Brent Palmer, PhD, associate professor of allergy and clinical immunology, hypothesizes that "long COVID" is caused by hidden viral reservoirs that remain in the body after the initial infection. Read this story here: https://bit.ly/41jSXGT See the other top stories here: https://bit.ly/4aeDZFY #COVID19 #Pandemic

Check out this recent journal article from TMS Medical Advisory Board member Dr. Joseph Butterfield (and Dr. Kathleen Bartemes); "Metformin: A potential adjunct for treatment of systemic mastocytosis." This is an open-access article published last month and will be included in the February 2024 issue of the Journal of Allergy and Clinical Immunology Global. We think the preliminary findings in this article are pretty exciting. https://buff.ly/3S0X9s5

In this month's episode of Hadassah On Call: New Frontiers in Medicine, we welcome Dr. Yuval Tal, director of the Allergy and Clinical Immunology Unit at Hadassah Hospital Ein Kerem | https://lnkd.in/dYFDM-uw Dr. Tal shares the latest advancements in clinical immunology, focusing on personalized treatments and biological medicine. He also highlights his department's expertise in treating various immunological diseases. ⏺ Is there a link between #PTSD and allergies? ⏺ How does Dr. Tal's department use precision medicine to advance treatments in clinical #immunology? ⏺ Is there a specific group of people who may be more susceptible to #COVID-19? ⏺ How are protective antibodies used? 📹 https://lnkd.in/dYFDM-uw

Is exercise linked to relieving symptoms of osteoarthritis? Leigh Callahan, PhD, with the Division of Rheumatology, Allergy, and Immunology, and Associate Director of the Thurston Arthritis Research Center details how measured exercise benefits her patients with OA. Studies show that the right kind of exercise can decrease swelling, stiffness, and the ability to perform everyday tasks. It is recommended to start slow, consult your doctor before implementing an exercise routine, and move to challenge your body without causing pain. #UNC #DeptofMed #unchealth #rheumatology #osteoarthritis #medicalresearch #osteoarthritisresearch #exercise 🔗 https://ow.ly/ql1850QWCnc

“Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study” was recently published online in Allergy, Asthma & Clinical Immunology. This innovative study linked patient support program data with provincial administrative data to demonstrate a significant reduction in: asthma exacerbations and asthma-related Healthcare Resource Utilization as well as associated costs, for patients receiving mepolizumab in a real-world Canadian setting. It is jointly authored by University Health Network, GSK, Western University, and IQVIA Canada. https://bit.ly/4c5l9ls #RealWorldEvidence #asthma #mepolizumab Callahan Laforty Brad Millson Shane Golden Kenneth Chapman Christopher Licskai

Cutaneous involvement in patients with Systemic Lupus Erythematosus: let’s talk about it! Three days full of lectures here in Turin, Italy, for the annual congress of allergy and clinical immunology.

The International Severe Asthma Registry (ISAR)’s new study, “Exploring definitions and predictors of response to biologics for severe asthma”, published in The Journal of Allergy and Clinical Immunology: In Practice (JACI: In Practice), explores the effectiveness of biologic treatments in adults with severe asthma. Given the variability in asthma response based on differing definitions, this study focuses on identifying predictors of response and examining residual symptoms post-treatment. Read the full press release: https://lnkd.in/gJRe-SFy Read the full article here: https://lnkd.in/gGxKa37g #ResearchInRealLife #SevereAsthma #Asthma #Research

The International Severe Asthma Registry (ISAR)’s new study, “Exploring definitions and predictors of response to biologics for severe asthma”, published in The Journal of Allergy and Clinical Immunology: In Practice (JACI: In Practice), explores the effectiveness of biologic treatments in adults with severe asthma. Given the variability in asthma response based on differing definitions, this study focuses on identifying predictors of response and examining residual symptoms post-treatment. Read the full press release: https://lnkd.in/gJRe-SFy Read the full article here: https://lnkd.in/gGxKa37g #ResearchInRealLife #SevereAsthma #Asthma #Research

The International Severe Asthma Registry (ISAR)’s new study, “Exploring definitions and predictors of response to biologics for severe asthma”, published in The Journal of Allergy and Clinical Immunology: In Practice (JACI: In Practice), explores the effectiveness of biologic treatments in adults with severe asthma. Given the variability in asthma response based on differing definitions, this study focuses on identifying predictors of response and examining residual symptoms post-treatment. Read the full press release: https://lnkd.in/gJRe-SFy Read the full article here: https://lnkd.in/gGxKa37g #ResearchInRealLife #SevereAsthma #Asthma #Research

Gout significantly impacts patients’ cardiovascular health and quality of life. Going beyond episodic treatment of acute flares and adopting a long-term approach to managing gout is therefore crucial for enhancing patients’ health outcomes. Adj A/Prof Bernard Thong, Senior Consultant in the Department of Rheumatology, Allergy and Immunology in Tan Tock Seng Hospital and Chairperson of the Gout ACE Clinical Guidance (ACG) Expert Group shared how clinicians can look to the ACG Gout — achieving the management goal for evidence-based recommendations to aid them in managing gout long term.   Read the ACG now: https://go.gov.sg/aceli169 #ACE #ACG #ClinicalGuidances #ClinicalGuidelines #gout #ULT #urateloweringtherapy